StreetInsider.com News Articles

DA Davidson Starts Emerson (EMR) at Neutral

Tue, 16 Jun 2026 07:31:49 -0400

(Updated - June 16, 2026 7:31 AM EDT)

DA Davidson analyst Chris Dankert initiates coverage on Emerson (NYSE: EMR) with a Neutral rating, PT $145.00.

The analyst comments "We are initiating coverage of Emerson Electric (EMR) with a ‘NEUTRAL’ rating and a $145 price target, which reflects 20.0x our FY27 adj. EPS forecast of $7.25. EMR enjoys significant exposure to secular tailwinds including increasing power generation demands, LNG investment, and near/re-shoring investment, and is executing on $10B of shareholder friendly capital deployment (dividends & buyback). However, the shares have struggled to break out of their multiple trading range and large project delays

DA Davidson Starts Emerson (EMR) at Neutral

Tue, 16 Jun 2026 07:31:49 -0400

(Updated - June 16, 2026 7:31 AM EDT)

DA Davidson analyst Chris Dankert initiates coverage on Emerson (NYSE: EMR) with a Neutral rating, PT $145.00.

Bernstein SocGen Group Starts Emerson (EMR) at Outperform

Tue, 09 Jun 2026 16:26:24 -0400

(Updated - June 9, 2026 4:26 PM EDT)

Bernstein SocGen Group analyst Varun Govindaraj initiates coverage on Emerson (NYSE: EMR) with a Outperform rating and a price target of $175.00.

The analyst comments "We think the story around Emerson depends on whether you believe their long-term value-creation algorithm (which implies the stock is under-priced); while the market is clearly debating this, we think EMR is well positioned to deliver on their framework. EMR’s 4 – 7% through-cycle target seems achievable; we believe they will land closer to 6% through-cycle; driven by LNG, Power, Pharma., Semis., A&D, and EV, tailwinds with additional support

Bernstein SocGen Group Starts Emerson (EMR) at Outperform

Tue, 09 Jun 2026 16:26:24 -0400

(Updated - June 9, 2026 4:26 PM EDT)

Bernstein SocGen Group analyst Varun Govindaraj initiates coverage on Emerson (NYSE: EMR) with a Outperform rating and a price target of $175.00.

Morgan Stanley sees organic growth upside in select industrials

Tue, 09 Jun 2026 07:30:17 -0400

Investing.com -- Morgan Stanley analysts identified several industrial companies positioned for organic growth upside based on their ability to exceed near-term forecasts and deliver earnings revisions.

The firm's stock selection focuses on companies that can deliver next-twelve-month organic upside, which drives both earnings per share revisions and relative valuation. Analysts noted that when out-year organic estimates are revised higher or lower, multiples typically follow the same direction.

Rockwell Automation (NYSE:ROK), Regal Rexnord (NYSE:RRX), Grainger (NYSE:GWW), and Parker-Hannifin (NYSE:PH) screened as most attractive. All four are modeled for deceleration but offer upside opportunity, supported by favorable end markets.